Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Translational Vision Science & Technology

• Publication date

  2015-05-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1167/TVST.4.3.1PMID 25964868PMCID PMC4418434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional Characterization and Molecular Identification of Vitamin C Transporter (SVCT2) in Human Corneal Epithelial (HCEC) and Retinal Pigment Epithelial (D407) Cells

  2015cited by this paper
• Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery

  2014cited by this paper
• Optimization of Dexamethasone Mixed Nanomicellar Formulation

  2014cited by this paper
• Novel Strategies for Anterior Segment Ocular Drug Delivery

  2013cited by this paper
• A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.

  2012cited by this paper
• Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model

  2012cited by this paper
• Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

  2012cited by this paper
• Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.

  2011cited by this paper
• Topical Loteprednol Pretreatment Reduces Cyclosporine Stinging in Chronic Dry Eye Disease

  2011cited by this paper
• Topical Cyclosporine 0.05% for the Prevention of Dry Eye Disease Progression

  2010cited by this paper
• Iontophoretic transport of charged macromolecules across human sclera.

  2010cited by this paper
• In Vitro Response of Retinal Pigment Epithelial Cells Exposed to Chitosan Materials Prepared with Different Cross-Linkers

  2010cited by this paper
• Topical ophthalmic cyclosporine: pharmacology and clinical uses.

  2009cited by this paper
• Interaction of Ocular Hypotensive Agents (PGF2α Analogs—Bimatoprost, Latanoprost, and Travoprost) With MDR Efflux Pumps on the Rabbit Cornea

  2009cited by this paper
• In vitro assessments of nanomaterial toxicity.

  2009cited by this paper
• Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.

  2008cited by this paper
• Effect of Viscosity on Tear Drainage and Ocular Residence Time

  2008cited by this paper
• Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.

  2007cited by this paper
• Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.

  2002cited by this paper
• Drug delivery to the posterior segment from drops.

  2002cited by this paper
• Determination of critical micelle concentration (CMC) of nonionic surfactants by donor-acceptor interaction with lodine and correlation of CMC with hydrophile-lipophile balance and other parameters of the surfactants

  2001cited by this paper
• Mechanisms of action of cyclosporine.

  2000cited by this paper
• Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.

  1999cited by this paper
• Topical cyclosporine inhibits mast cell-mediated conjunctivitis.

  1996cited by this paper
• Ocular absorption following topical delivery

  1995cited by this paper
• Ocular drug delivery conventional ocular formulations

  1995cited by this paper
• Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome

  1994cited by this paper
• Pilot Trial of Cyclosporine 1% Ophthalmic Ointment in the Treatment of Keratoconjunctivitis Sicca

  1993cited by this paper
• Light-scattering study of the association behavior of styrene-ethylene oxide block copolymers in aqueous solution

  1991cited by this paper

• Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Dye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study

  2026influential citation
• Polyphenols-composed micelles: production, physicochemical characterization, in silico pharmacokinetics, and rheological behaviour of a new colloidal system for dual delivery of resveratrol and rutin.

  2026cites this paper
• Optimization and Evaluation of Polymeric Mixed Nanomicelles for Ocular Delivery to the Posterior Eye Segment

  2025cites this paper
• Selective Tissue Penetration of the Corneal Layers of Cyclosporin 2% Associated with Miglyol in Rabbits

  2025cites this paper
• Clinical Efficacy and Safety of Preservative Free Cyclosporine in Dry Eye Disease

  2025cites this paper
• Polymeric Micelles in Targeted Breast Cancer Therapy：Recent Advances and Future Trends

  2025cites this paper
• Breaking Barriers in Ocular Drug Delivery for Uveitis: Advanced Drug Delivery Systems, Challenges and Future Prospects.

  2025cites this paper
• From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics

  2025cites this paper
• Effect of OTX-101 0.09% ciclosporin solution on clinical signs of dry eye disease in patients with moderate-to-severe corneal damage: a post-hoc analysis of randomized clinical trials.

  2025cites this paper
• Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment

  2024cites this paper
• Nanomicellar eye drops: a review of recent advances

  2024cites this paper
• Recent progress of nanomedicine in managing dry eye disease

  2024influential citation
• Eye Posterior Segment Drug Delivery and Nanomicelles as a Drug Delivery System for Age-Related Macular Degeneration

  2024cites this paper
• Current Insights into Targeting Strategies for the Effective Therapy of Diseases of the Posterior Eye Segment.

  2024cites this paper
• Design, Formulation, and Evaluation of Opthalmic Multilayer Nanofiber Insert for Management of Dry Eye Disease

  2024cites this paper
• Recent Progress in Polymeric Micelle-Enabled Targeted Nanotherapeutics for Diabetic Retinopathy

  2024cites this paper
• Anti-inflammatory effects of LCB 03-0110 on human corneal epithelial and murine T helper 17 cells

  2024cites this paper
• Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer.

  2024cites this paper
• Novel fabrication of anti-VEGF drug ranibizumab loaded PLGA/PLA co-polymeric nanomicelles for long-acting intraocular delivery in the treatment of age-related macular degeneration therapy

  2024cites this paper
• A Simple Approach to Preparation of Surfactant Nano-Micelles Loaded Drugs

  2024cites this paper
• Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies.

  2023cites this paper
• Role of Polymeric Micelles in Ocular Drug Delivery: An Overview of Decades of Research.

  2023cites this paper
• Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases.

  2023cites this paper
• Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases

  2023cites this paper
• Updates on Biodegradable Formulations for Ocular Drug Delivery

  2023cites this paper
• Exploring the Therapeutic Potential of Cyclosporine for Ophthalmic Indications by Novel Carrier Systems.

  2023cites this paper
• Development of Dexamethasone Loaded Nanomicelles Using a 3d Printed Microfluidic Device for Ocular Drug Delivery Applications

  2023cites this paper
• Self-Assembled Nanomicellar Formulation of Docetaxel as a Potential Breast Cancer Chemotherapeutic System

  2022cites this paper
• Application of Nanomicelles in Enhancing Bioavailability and Biological Efficacy of Bioactive Nutrients

  2022cites this paper
• PHYSICAL CHARACTERIZATION OF IN SITU OPHTHALMIC GEL: A CONCISE REVIEW

  2022cites this paper
• Selective Pharmacologic Therapies for Dry Eye Disease Treatment: Efficacy, Tolerability, and Safety Data Review from Preclinical Studies and Pivotal Trials

  2022cites this paper
• Novel drug delivery systems for the management of dry eye.

  2022cites this paper
• Antiangiogenic Nanomicelles for the Topical Delivery of Aflibercept to Treat Retinal Neovascular Disease

  2021cites this paper
• A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability.

  2021cites this paper
• Polymeric Micelles for the Enhanced Deposition of Hydrophobic Drugs into Ocular Tissues, without Plasma Exposure

  2021cites this paper
• Ocular Distribution of Papaverine Using Non-aqueous Vehicles

  2021cites this paper
• Nanomicelles: Types, properties and applications in drug delivery

  2021cites this paper
• OPTH_A_279364 129..140

  2021cites this paper
• Cyclosporine A Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Cationic Nanoparticles and Drug-Core Mucus Penetrating Nanoparticles.

  2021cites this paper
• Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective

  2021cites this paper
• Aplicações Clínicas da Ciclosporina Tópica em Oftalmologia: Revisão para Oftalmologistas

  2021cites this paper
• The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye

  2021cites this paper
• Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

  2021cites this paper
• A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These Trials

  2020cites this paper
• Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone.

  2020cites this paper
• Current and Future Pharmacological Therapies for the Management of Dry Eye.

  2020cites this paper
• Recent developments in nano micelles as drug delivery system

  2020cites this paper
• OPTH_A_228838 119..126

  2020cites this paper
• Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

  2020cites this paper
• A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

  2020cites this paper
• Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A

  2020cites this paper
• Chronic Ocular Graft Versus Host Disease: An Update and Review

  2020cites this paper
• The Role Of Nano- Ophthalmology In Treating Dry Eye Disease.

  2020cites this paper
• A Novel Eyes Topical Drug Delivery System: CsA-LNC for the Treatment of DED

  2020cites this paper
• Prodrugs and nanomicelles to overcome ocular barriers for drug penetration

  2020influential citation
• Recent Advances of Nanocarriers for Effective Delivery of Therapeutic Peptides

  2020cites this paper
• Self-Assembling Tacrolimus Nanomicelles for Retinal Drug Delivery

  2020cites this paper
• A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments

  2020cites this paper
• Automated detection of glaucoma with interpretable machine learning using clinical data and multi-modal retinal images

  2020cites this paper
• OPTH_A_228070 481..489

  2020influential citation
• Multi-Layered Nanomicelles as Self-Assembled Nanocarrier Systems for Ocular Peptide Delivery

  2019cites this paper
• A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin

  2019cites this paper
• Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics

  2019cites this paper
• Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles

  2019cites this paper
• Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease

  2019cites this paper
• Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents

  2019cites this paper
• Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study.

  2019cites this paper
• Treatment of Endotoxin-Induced Uveitis by Topical Application of Cyclosporine A-Loaded PolyGelTM in Rabbit Eyes.

  2019cites this paper
• Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention

  2019cites this paper
• A review on recent drug delivery systems for posterior segment of eye.

  2018cites this paper
• Ocular delivery of proteins and peptides: Challenges and novel formulation approaches☆

  2018cites this paper
• Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.

  2018cites this paper
• Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model

  2018cites this paper
• Clear, Aqueous Topical Drop of Triamcinolone Acetonide

  2017cites this paper
• Topical Formulation of Self-Assembled Antiviral Prodrug Nanomicelles for Targeted Retinal Delivery.

  2017cites this paper
• Nanomicelles in Diagnosis and Drug Delivery

  2017cites this paper
• Therapeutic Applications of Polymeric Materials

  2017cites this paper
• Conventional and Advanced Ocular Formulation and Delivery: A Mini Review

  2017influential citation
• Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases

  2017cites this paper
• Ocular bioanalysis: challenges and advancements in recent years for these rare matrices.

  2017cites this paper
• Recent perspectives on the delivery of biologics to back of the eye

  2017cites this paper
• Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome

  2017cites this paper
• The Indecision Model of Psychophysical Performance in Dual-Presentation Tasks: Parameter Estimation and Comparative Analysis of Response Formats

  2017cites this paper
• RES-loaded pegylated CS NPs: for efficient ocular delivery.

  2017cites this paper
• Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts

  2017cites this paper
• Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

  2017cites this paper
• Multiplexing Prisms for Field Expansion.

  2017cites this paper
• Intraoperative Optical Coherence Tomography Enables Noncontact Imaging During Canaloplasty

  2016cites this paper
• Primary visual cortical remapping in patients with inherited peripheral retinal degeneration

  2016cites this paper
• Advance of the application of nano-controlled release system in ophthalmic drug delivery

  2016cites this paper
• Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

  2016cites this paper
• Cyclosporine Amicellar delivery system for dry eyes

  2016cites this paper
• Modern approaches to the ocular delivery of cyclosporine A.

  2016cites this paper
• Dry Eye Disease: Present Challenges in the Management and Future Trends.

  2016cites this paper
• Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).

  2016cites this paper
• Photokinetic Drug Delivery: Light-Enhanced Permeation in an In Vitro Eye Model

  2015cites this paper
• Study on Cyclosporine Micelles for the Treatment of Dry Eye Syndrome

  year unknowncites this paper
• Formulation, Characterization, and Evaluation of Ticagrelor-loaded Nano Micelles Enhance Intestinal Absorption

  year unknowncites this paper